Evaluation of performance of quantiferon assay and tuberculin skin test in end stage renal disease patients receiving hemodialysis

New Microbiologica

Volumn 34, Issue 4, 2011, Pages 351-356

  Maden, Emin ^a   Bekci, T Taha ^b   Kesli, Recep ^c   Atalay, Huseyin ^a   Teke, Turgut ^a   Solak, Yalcin ^a   Turk, Suleyman ^a   Uzun, Kursat ^a   Koylu, Ramazan ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b Konya Education and Research Hospital   (Turkey)

^c Konya Education and Research Hospital   (Turkey)

Author keywords

Hemodialysis; Quantiferon test; Tuberculosis

Indexed keywords

BCG VACCINE;

ADULT; AGED; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; LUNG TUBERCULOSIS; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY; REVIEW; RISK FACTOR; STANDARD; TUBERCULIN TEST; VALIDATION STUDY;

ADULT; AGED; BCG VACCINE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 82755165278     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. AMERICAN THORACIC SOCIETY (ATS) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). (2000). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161, S221-S247.
2. AMICOSANTE M., CICCOZZI M., MARKOVA R. (2010). Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies. New Microbiol. 33, 93-107.
3. ANDREW O.T., SCHOENFELD P.Y., HOPEWELL P.C. (1980). Tuberculosis in patients with end-stage renal disease. Am. J. Med. 68, 59.
4. CENGIZ K. (1996). Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron. 73, 421.
5. DIEL R., LODDENKEMPER R., MEYWALD-WALTER K., NIEMANN S., NIENHAUS A. (2008). Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 177, 1164-1170. (Pubitemid 351717577)
6. ELBEK O., UYAR M., AYDIN N., BÖREKÇI S., BAYRAM N., BAYRAM H., DIKENSOY O. (2009). Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha. Clin. Rheumatol. 28, 421-426.
7. HICKSTEIN L., MCPHERSON C., KWALICK D. (2004). Tuberculosis transmission in a renal dialysis center. Nevada, 2003. MMWR. 53, 873-875.
8. HUSSEIN M.M., MOOIJ J.M., ROUJOULEH H. (2003). Tuberculosis and chronic renal disease. Semin. Dial. 16, 38.
9. INOUE T., NAKAMURA T., KATSUMA A., MASUMOTO S., MINAMI E., KATAGIRI D. (2009). The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol. Dial. Transplant. 24, 2252-2257.
10. JONES S., DE GIJSEL D., WALLACH F.R., GURTMAN A.C., SHI Q., SACKS H. (2007). Utility of QuantiFERONTB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int. J. Tuberc. Lung. Dis. 11, 1190-1195. (Pubitemid 350146299)
11. KOBASHI Y., MOURI K., OBASE Y. (2007). Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur. Respir. J. 30, 945-950. (Pubitemid 351194799)
12. KÜRS?AT S., OZGÜR B. (2001). Increased incidence of tuberculosis in chronic hemodialysis patients. Am. J. Nephrol. 21, 490-493. (Pubitemid 34088206)
13. KURTZ P., KOHLER H., MENER S. (1986). Impaired cellular immune responses in chronic renal failure: Evidence for a T-cell defect. Kidney Int. 29, 1209-1214. (Pubitemid 16094235)
14. LEE S.S.J., CHOU K.J., SU I.J., CHEN Y.S. (2009). High Prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection. 37, 96-102.
15. LEUNG C.C., YAM W.C., YEW W.W., HO P.L., TAM C.M., LAW W.S. (2008). Comparison of T-Spot.TB and tuberculin skin test among silicotic patients. Eur. Respir. J. 31, 266-272.
16. LUETKEMEYER A.F., CHARLEBOIS E.D., FLORES L.L., BANGSBERG D.R., DEEKS S.G., MARTIN J.N. (2007). Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am. J. Respir. Crit. Care Med. 175, 737-742. (Pubitemid 46536491)
17. MENZIES D., PAI M., COMSTOCK G. (2007). Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146, 340-354. (Pubitemid 351650594)
18. MITWALLI A. (1991). Tuberculosis in patients on maintenance dialysis. Am. J. Kidney Dis. 18, 579-582.
19. OZDEMIR D., ANNAKKAYA A.N., TARHAN G., SENCAN I., CESUR S., BALBAY O., GUCLU E. (2007). Comparison of the tuberculin skin test and the quantiferon test for latent Mycobacterium tuberculosis infections in health care workers in Turkey. Jpn. J. Infect. Dis. 60, 102-5. (Pubitemid 47009525)
20. PAI M., O'BRIEN R. (2008). Review of T-cell-based assays for the diagnosis of latent tuberculosis infection. Ann. Intern. Med. 149, 1-12.
21. PASSALENT L., KHAN K., RICHARDSON R. (2007). Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the TSPOT. TB test, tuberculin skin test, and an expert physician panel. Clin. J. Am. Soc. Nephrol. 2, 68-73.
22. PIANA F., CODECASA L.R., CAVALLERIO P. (2006). Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur. Respir. J. 28, 31-34. (Pubitemid 44914257)
23. RAVI SHANKARM.S., ARAVINDAN A.N., SOHAL P.M. (2005). The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol. Dial. Transplant. 20, 2720-2724. (Pubitemid 41672271)
24. SEYHAN E.C., SÖKÜCÜ S., ALTIN S. (2009). Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl. Infect. Dis. 10 (Epub ahead of print)
25. SMIRNOFF M., PATT C., SECKLER B. (1998). Tuberculin and anergy skin testing of patients receiving longterm hemodialysis. Chest. 113, 25-27. (Pubitemid 28044919)
26. SOYSAL A., TORUN T., EFE S., GENCER H., TAHAOGLU K., BAKIRM. (2008). Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int. J. Tuberc. Lung. Dis. 12, 50-56.
27. TRIVERIO P.A., BRIDEVAUX P.O., ROUX-LOMBARD P., NIKSIC L., ROCHAT T., MARTIN P.Y. (2009). Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol. Dial. Transplant. 24, 1952-1956.
28. VIERA A.J., GARRETT J.M. (2005). Understanding interobserver agreement: the kappa statistic. Fam. Med. 37, 360-363. (Pubitemid 40656185)
29. WINTHROP K.L., NYENDAK M., CALVET H., OH P., LO M., SWARBRICK G. (2008). Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin. J. Am. Soc. Nephrol. 3, 1357-1363.
30. WOELTJE K.F., MATHEW A., ROTHSTEIN M., SEILER S., FRASER V.J. (1998). Tuberculosis infection and anergy in hemodialysis patients. Am. J. Kidney. Dis. 31, 848-852. (Pubitemid 28234638)